Portnoy Law Firm Announces Class Action on Behalf of The Chemours Company Investors

LOS ANGELES, Oct. 14, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises The Chemours Company, (“Chemours” or the “Company”) (NYSE: CC) investors of a class action on behalf of investors that bought securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemour investors have until December 7, 2026 to file a lead plaintiff motion.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/the-chemours-company. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

Following Congress’s late 2020 passage of the U.S. AIM Act—which authorized the EPA to manage the shift toward lower-impact refrigerants—Chemours asserted that regulatory adoption was propelling consistent, double-digit growth for its Opteon line. Building on this momentum, the company issued full-year 2026 guidance forecasting net sales growth of 3% to 5% and adjusted EBITDA between $800 million and $900 million, citing elevated demand for Opteon products. However, the complaint alleges that Chemours omitted critical market conditions, failing to disclose that clients had pre-stocked Opteon inventory due to the AIM Act transition, which left commercial channels oversupplied entering 2026. These underlying inventory imbalances were exposed on August 4, 2026, when Chemours published its second-quarter 2026 financial metrics. The company disclosed a roughly 1% year-over-year decline in net sales and lowered its 2026 adjusted EBITDA outlook by nearly 11% to a new range of $775 million to $825 million. Executive commentary acknowledged that customers had accumulated surplus inventory during the prior year, aftermarket channels were saturated, and sales were being made into an oversupplied marketplace. In response to these revelations, Chemours’s share price plummeted $3.34, or 18.63%, dropping from its August 4 closing price of $17.93 to close at $14.59 per share on August 5, 2026.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising

Media gallery